The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis

BACKGROUND: Hepatitis C virus (HCV) infection is an independent risk factor associated with adverse outcomes in patients with end-stage renal disease (ESRD). Due to the wide variety of direct-acting antiviral regimens (DAAs) and the factor of renal insufficiency, careless selection of anti-hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ruochan, Xiong, Yinghui, Zeng, Yanyang, Wang, Xiaolei, Xiao, Yinzong, Zheng, Yixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570741/
https://www.ncbi.nlm.nih.gov/pubmed/37841743
http://dx.doi.org/10.3389/fpubh.2023.1179531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570741/
https://www.ncbi.nlm.nih.gov/pubmed/37841743
http://dx.doi.org/10.3389/fpubh.2023.1179531

Ejemplares similares